Gastro Medical News about Colitis, Ulcerative

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

5-ASA in ulcerative colitis: Improving treatment compliance
World Journal of Gastroenterology, 10/01/09

Prantera C et al. – 5–aminosalicylic acid (5–ASA) compounds are a highly effective treatment for ulcerative colitis (UC). While UC patient compliance in clinical studies is over 90%, only 40% of patients in every day life take their prescribed therapy. 5–ASA MMx seems theoretically the best agent for maintaining patient compliance, and consequently, treatment effectiveness.

<< Previous
Risk factors for recurrence of autoimmune hepatitis after liver...

Next >>
Rejection of Permacol mesh used in abdominal wall repair: A case...